A weekly assessment of U.S. Treasury liquidity, auction demand, funding conditions, dealer intermediation, and market-functioning risk, with practical implications for portfolio, treasury, and risk decision-makers.
When compliance breaks, capital follows. Explore how FDA 483 compliance risk silently shapes liquidity, valuation, and investor confidence and why predictability has become the new compliance.
